No clear survival benefit of azacitidine for lower‐risk...

  • Main
  • 2020 / 10
  • No clear survival benefit of azacitidine for lower‐risk...
Cancer Science 2020 / 10

No clear survival benefit of azacitidine for lower‐risk myelodysplastic syndromes: A retrospective study of Nagasaki

Toriyama, Eo, Hata, Tomoko, Yokota, Ken‐ichi, Chiwata, Masahiko, Kamijo, Rena, Hashimoto, Miki, Taguchi, Masataka, Horai, Makiko, Matsuo, Masatoshi, Matsuo, Emi, Takasaki, Yumi, Kawaguchi, Yasuhisa,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer Science
DOI:
10.1111/cas.14653
Date:
October, 2020
File:
PDF, 527 KB
2020
Conversion to is in progress
Conversion to is failed